Clinical Trial Update: Feasibility and Safety of MB-102 in Ocular Angiography as Compared to Fluorescein Sodium [EARLY_Phase 1]

View source ↗

Summary

Phase 1 feasibility and safety trial evaluating MB-102 for ocular angiography versus fluorescein sodium is currently recruiting. The study targets retinal disea…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Age-related Macular Degeneration
• Diabetic Retinopathy
• Retinal Vein Occlusion

Drugs mentioned

• Fluorescein Sodium (fluorescein sodium)
• MB-102

Snippet

Sponsor: MediBeacon | Conditions: Retinopathy, Retinal Vein Occlusion | EARLY_Phase 1 | Status: RECRUITING